Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DG (Directorate General) Research on embryonic stem cell issues:

This article was originally published in Clinica

Executive Summary

The issues surrounding human embryonic stem cell research are tackled in a report just released by the European Commission's Directorate General Research. The paper examines the scientific, ethical, socio-economic and governance aspects of human stem cell research and outlines the potential benefits of such research and the pros and cons of using stem cells from different sources. It reviews the current state of legislation in various EU member states and some non-EU countries as well as the governance of human stem cell research under the European Commission's Sixth Framework Programme.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel